ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase II ABT-888 With Cyclophosphamide

National Cancer Institute (NCI) · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
breast-cancerovarian-cancerpharmacodynamicstriple-negative-breast-cancer
ovarian cancer, primary peritoneal cancer, serous carcinoma cancer, triple-negative breast cancer, fallopian tube cancer, parp inhibitor, brca mutations, dna damage repair, pharmacodynamics, metronomic cyclophosphamide, breast cancer, peritoneal cancer
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 801943
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.